Gavin Choy - 31 Dec 2021 Form 4 Insider Report for GT Biopharma, Inc. (GTBP)

Role
Acting Chief Financial Officer
Signature
/s/ Gavin Choy
Issuer symbol
GTBP
Transactions as of
31 Dec 2021
Net transactions value
$0
Form type
4
Filing time
14 Feb 2022, 15:09:22 UTC
Previous filing
14 Feb 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GTBP Option to purchase Common Stock Award $0 +227,500 $0.000000 227,500 31 Dec 2021 Common Stock 227,500 $3.05 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 33% on the date of grant, 33% on 6/1/22 and 34% on 6/1/23, subject to continued service and subject to full acceleration immediately prior to the consummation of a change of control.